Compound atlas
Healing

Thymosin α1

Also known as · Tα1 · Zadaxin

PeptidePrescription drug
Half-life
2h
approx. mean t½
Dose range
1.6 mg / 2× week
typical, not prescriptive
Category
Healing
primary use-case
Single-dose decay
t½ = 2h · first-order model
~8h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m2h4h6h8h10h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

An immunomodulatory peptide approved in many countries for chronic hepatitis B and as a cancer adjuvant; used off-label for immune support.

Mechanism of action

Promotes T-cell maturation and enhances dendritic-cell function and Th1 responses.

Typical protocol

1.6 mg subQ 2× weekly, in 4–12 week cycles.

Storage

Reconstituted: refrigerated, ~14 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.